Board and auditor

Lars Thunberg Chairman of the Board

Lars Thunberg, born 1966, is a co-founder of CombiGene and chaired its board during the period Aug. 2013 to Oct. 2014. He serves as chairman of several companies, for example VA Automotive AB (publ), which are listed on NASDAQ First North. Lars holds an MSc in Business Administration and Economics from Stockholm University and Lund University.

Elizabeth Willis Board member

Dede Willis has over 30 years of international experience in start-ups and turn-arounds. She has expertise in strategic planning & execution, acquisition negotiation & integration, product development from concept to commercialization, FDA and CE Marking regulatory processes for drugs & devices, as well as sales & marketing.  Dede Willis spent the first 15 years of her career with the former Hoechst Group (now Sanofi, Celanese, and DuPont) where she worked in several corporate start-ups in the U.S. and Germany. Her last position with the Hoechst Group was President and CEO of a large subsidiary. She has managed the development and launch of multiple products including medical devices and veterinary diagnostics. She was co-founder, COO and Board Member of Boulder Diagnostics Inc, whose technology was acquired by Oxford Immunotec. She was responsible for the development and launch of veterinary diagnostic products for Lyme disease and parasite detection.  Dede holds a B.Sc. in Chemical engineering from Clemson University and an MBA from the University of Houston.

Nerry Kamstrup Board member

Nerry Kamstrup is an experienced veterinary practitioner and has extensive expertise from animal clinics in Fakse, Vordingborg and Husum. She worked in several countries, e.g. in Maryland, USA, where she served as expert in ophthalmology (eye diseases) at a companion animal clinic. Nerry is authorised by the Danish veterinary eye-disease panel since 2006 and has a great passion for treatment and surgery of eye diseases in all animal species. She is also certified by The European College of Veterinary Ophthalmologists (ECVO), which requires that she participates in many courses and congresses within the field of eye diseases. Nerry holds a degree as Doctor of Veterinary Medicine (DVM) from Copenhagen.

Lars Friis Mikkelsen Board member

Lars Friis Mikkelsen is an experienced in-vivo pharmacology experts. He is the CEO of Ellegaard Göttingen Minipigs that produces experimental pigs for research purposes. He is also the founder of the company LarSolution that offers advice on pharmacological development and business development in the pharmaceutical field. Lars worked with pharmacology and experimental animals, including animal protection and welfare, for many years in Novo Nordisk and MSD/Merck, latest as Head of in-vivo pharmacology. Early in his career he worked as a veterinary practitioner in Rønde, Denmark. He is a Board member of the European Animal Research Association (EARA) and Chairman of the Large Animals Topic Group, European Federation of Pharmaceutical Industries and Associations (EFPIA). Lars holds a Doctor of Veterinary Medicines degree (DVM) from Copenhagen, 1994.

Revisor

Anders Persson Auditor

Mazars SET Revisionsbyrå AB

Subscribe

Press releases and reports via E-mail.